PREVENTION OF LOW CARDIAC OUTPUT SINDROME IN NEWBORNS UNDERGOING CARDIAC SURGERY: A PILOT STUDY ABOUT DOSE-DEPENDENT PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 INODILATORS

Trial Profile

PREVENTION OF LOW CARDIAC OUTPUT SINDROME IN NEWBORNS UNDERGOING CARDIAC SURGERY: A PILOT STUDY ABOUT DOSE-DEPENDENT PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 INODILATORS

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2012

At a glance

  • Drugs Levosimendan (Primary) ; Milrinone (Primary)
  • Indications Heart failure; Low cardiac output
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 07 Nov 2012 Planned End Date changed to 12 Jun 2010.
    • 27 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top